At present, the clinical treatment of hyperuricaemia is mostly related to the inhibition of xanthine oxidase, and the commonly used xanthine oxidase inhibitors and drugs include allopurinol, febuxostat, topiostat, etc. [18], and there is still a large space for the research of designing and developing the inhibitors based on the main raw materials of Chinese herbs. This evidence concerns the gene XDH and hyperuricemia.